N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

Gross Margin
NewGLab Pharma Co Ltd

-13.2%
Current
8%
Average
24.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-13.2%
=
Gross Profit
-805.1m
/
Revenue
6.1B

Gross Margin Across Competitors

Country KR
Market Cap 323.6B KRW
Gross Margin
-13%
Country JP
Market Cap 15.6T JPY
Gross Margin
84%
Country CN
Market Cap 288.1B CNY
Gross Margin
44%
Country US
Market Cap 28.2B USD
Gross Margin
63%
Country SE
Market Cap 283.3B SEK
Gross Margin
67%
Country US
Market Cap 21.9B USD
Gross Margin
43%
Country US
Market Cap 20.3B USD
Gross Margin
48%
Country US
Market Cap 17.5B USD
Gross Margin
63%
Country IL
Market Cap 14.2B USD
Gross Margin
47%
Country UK
Market Cap 10.3B GBP
Gross Margin
50%
Country JP
Market Cap 1.3T JPY
Gross Margin
43%
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-13.2%
=
Gross Profit
-805.1m
/
Revenue
6.1B
What is the Gross Margin of NewGLab Pharma Co Ltd?

Based on NewGLab Pharma Co Ltd's most recent financial statements, the company has Gross Margin of -13.2%.